Menu Search
Equities

Core Laboratories Inc

CLB:NYQ

Core Laboratories Inc

Actions
EnergyOil, Gas and Coal
  • Price (USD)21.12
  • Today's Change0.81 / 3.99%
  • Shares traded329.34k
  • 1 Year change+15.79%
  • Beta2.3714
Data delayed at least 15 minutes, as of Nov 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
Select bar for recommendation details.
Recommendations14-Nov-24
Buy0
Outperform1
Hold4
Sell1
Strong Sell1

Share price forecast in USD

The 7 analysts offering 12 month price targets for Core Laboratories Inc have a median target of 20.00, with a high estimate of 24.00 and a low estimate of 14.00. The median estimate represents a -5.30% decrease from the last price of 21.12.
High13.6%24.00
Med-5.3%20.00
Low-33.7%14.00

Dividends in USD

In 2023, Core Laboratories Inc reported a dividend of 0.04 USD, equaling last years dividend. The 5 analysts covering the company expect dividends of 0.04 USD for the upcoming fiscal year, maintaining dividends from this year.
Div growth (TTM)0.00%
More ▼

Earnings history & estimates in USD

On Oct 23, 2024, Core Laboratories Inc reported 3rd quarter 2024 earnings of 0.25 per share. This result was in line with the consensus of the 6 analysts following the company and exceeded last year's 3rd quarter results by 13.64%.
The next earnings announcement is expected on Feb 03, 2025.
Average growth rate+3.95%
Core Laboratories Inc reported annual 2023 earnings of 0.80 per share on Jan 31, 2024.
Average growth rate-11.28%
More ▼

Revenue history & estimates in USD

Core Laboratories N.V. had 3rd quarter 2024 revenues of 134.40m. This bettered the 134.04m consensus of the 5 analysts covering the company. This was 4.71% above the prior year's 3rd quarter results.
Average growth rate+1.76%
Core Laboratories N.V. had revenues for the full year 2023 of 509.71m. This was 4.08% above the prior year's results.
Average growth rate-5.59%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.